6fnk

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "6fnk" [edit=sysop:move=sysop])
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 6fnk is ON HOLD until Paper Publication
+
==Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712==
 +
<StructureSection load='6fnk' size='340' side='right' caption='[[6fnk]], [[Resolution|resolution]] 1.05&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[6fnk]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6FNK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6FNK FirstGlance]. <br>
 +
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=DXK:1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-amine'>DXK</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr>
 +
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Receptor_protein-tyrosine_kinase Receptor protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 2.7.10.1] </span></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6fnk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6fnk OCA], [http://pdbe.org/6fnk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6fnk RCSB], [http://www.ebi.ac.uk/pdbsum/6fnk PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6fnk ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[[http://www.uniprot.org/uniprot/EPHB4_HUMAN EPHB4_HUMAN]] Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Together with its cognate ligand/functional ligand EFNB2 plays a central role in heart morphogenesis and angiogenesis through regulation of cell adhesion and cell migration. EPHB4-mediated forward signaling controls cellular repulsion and segregation form EFNB2-expressing cells. Plays also a role in postnatal blood vessel remodeling, morphogenesis and permeability and is thus important in the context of tumor angiogenesis.<ref>PMID:12734395</ref> <ref>PMID:16424904</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Erythropoietin-producing hepatocellular (EPH) receptors are transmembrane receptor tyrosine kinases. Their extracellular domains bind specifically to ephrin A/B ligands, and this binding modulates intracellular kinase activity. EPHs are key players in bidirectional intercellular signaling, controlling cell morphology, adhesion, and migration. They are increasingly recognized as cancer drug targets. We analyzed the binding of NVP-BHG712 (NVP) to EPHA2 and EPHB4. Unexpectedly, all tested commercially available NVP samples turned out to be a regioisomer (NVPiso) of the inhibitor, initially described in a Novartis patent application. They only differ by the localization of a single methyl group on either one of two adjacent nitrogen atoms. The two compounds of identical mass revealed different binding modes. Furthermore, both in vitro and in vivo experiments showed that the isomers differ in their kinase affinity and selectivity.
-
Authors: KUDLINZKI, D., TROESTER, A., WITT, K., LINHARD, V.L., SAXENA, K., SCHWALBE, H.
+
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.,Troster A, Heinzlmeir S, Berger BT, Gande SL, Saxena K, Sreeramulu S, Linhard V, Nasiri AH, Bolte M, Muller S, Kuster B, Medard G, Kudlinzki D, Schwalbe H ChemMedChem. 2018 Jun 21. doi: 10.1002/cmdc.201800398. PMID:29928781<ref>PMID:29928781</ref>
-
Description: Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
[[Category: Unreleased Structures]]
+
</div>
-
[[Category: Linhard, V.L]]
+
<div class="pdbe-citations 6fnk" style="background-color:#fffaf0;"></div>
-
[[Category: Kudlinzki, D]]
+
== References ==
-
[[Category: Saxena, K]]
+
<references/>
-
[[Category: Witt, K]]
+
__TOC__
-
[[Category: Schwalbe, H]]
+
</StructureSection>
-
[[Category: Troester, A]]
+
[[Category: Receptor protein-tyrosine kinase]]
 +
[[Category: KUDLINZKI, D]]
 +
[[Category: LINHARD, V L]]
 +
[[Category: SAXENA, K]]
 +
[[Category: SCHWALBE, H]]
 +
[[Category: TROESTER, A]]
 +
[[Category: WITT, K]]
 +
[[Category: Complex]]
 +
[[Category: Inhibitor]]
 +
[[Category: Protein tyrosine kinase]]
 +
[[Category: Transferase]]

Revision as of 21:53, 9 August 2018

Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712

6fnk, resolution 1.05Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools